Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, Yinuo Meng, Whitney J. Sisso, Kenneth Seier, Gun Ho Jang, Henry Walch, Victoria G. Aveson, David J. Falvo, William B. Fall, Christopher W. Chan, Andrew Wenger, Brett L. Ecker, Alessandra Pulvirenti, Rebecca Gelfer, María Paz Zafra, Nikolaus Schultz, Wungki Park, Eileen M. O’Reilly, Shauna L Houlihan, Alicia Alonso, Erika Hissong, George M. Church, Christopher E. Mason, Despina Siolas, Faiyaz Notta, Mithat Gönen, Lukas E. Dow, William R. Jarnagin, Rohit Chandwani
Topics & Concepts
KRASPancreatic cancerPancreatic ductal adenocarcinomaAdenocarcinomaCancer researchMutantCancerMutationBiologyOncologyResectionMedicineInternal medicineBioinformaticsGeneGeneticsColorectal cancerSurgeryPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsNeuroendocrine Tumor Research Advances